Inspire Medical Systems Inc (INSP) FinancialsINSPInspire Medical Systems Inc

Evaluating the bottom line, Inspire Medical Systems, Inc. maintains a gross margin of 85.98%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -0.40%, while the net margin is -2.71%. These profitability ratios, combined with a Return on Equity (ROE) of 17.96%, provide a clear picture of how effectively INSP converts its operational activities into shareholder value.

In the context of the broader market, INSP competes directly with industry leaders such as BFLY and AXGN. With a market capitalization of $1.99B, it holds a significant position in the sector. When comparing efficiency, INSP's gross margin of 85.98% stands against BFLY's 71.41% and AXGN's 72.67%. Such benchmarking helps identify whether Inspire Medical Systems, Inc. is trading at a premium or discount relative to its financial performance.

In the latest quarter, Inspire Medical reported revenue of $200.6 million, which was above expectations, but it also showed a year-over-year decline of 7.6%. The gross margin remains strong at 85.48%, indicating solid profitability despite recent challenges.